Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
@neurIST : Intregrated Biomedical Informatics for the Management of Cerebral Aneurysms
NCT05526352 · View on ClinicalTrials.gov ↗
Study Summary
The primary aim of the SwissNeuroFoundation AneurysmDataBase Project is to implement information technology based tools to create and use a holistic reference database specific to intracranial aneurysms (IA). The SwissNeuroFoundation AneurysmDataBase are concerned with generating the data with which to populate this database. The purpose for populating the database are to: * Screen for and evaluate markers of risk for intracranial aneurysm formation and aneurysm rupture. Are considered as markers the following: genetics factors, microbiota, environmental factors, congenital factors (ie: cerebrovascular anatomical variants), transcriptomics signature, proteomics signature,shape characteristics, haemodynamics characteristics. * Screen for and evaluate prognostic factors of outcome regarding different management strategies including watchful observation, microsurgical treatment, endovascular treatment or any combination thereof. * Implement and evaluate patient-specific management protocols integrating all available information. * Evaluate the impact of the database and use of tools to improve care, reduce costs, support knowledge discovery and promote new industrial developments.
Conditions Studied
Study Locations (20)
Other
- Montreal Neurological Institute and Hospital, McGill University — Montreal
- Helsinki University Central Hospital — Helsinki
- Kuopio University Hospital — Kuopio
- ICAN — Nantes
- Department of Neurosurgery, Klinikum rechts der Isar, Technical University Munich — Munich
- University of Pecs — Pécs
- Erasmus Medical Center — Rotterdam
- University Medical Center Utrecht — Utrecht
- Jagiellonian University Medical College — Krakow
- Barcelona Hospital General de Cataluna — Barcelona
- Hospital Clinic Barcelona — Barcelona
- IMIM - Hospital del Mar — Barcelona
- Neurochirurgie / Hôpitaux Universitaire de Genève — Geneva
- University Hospital of Lausanne (CHUV), CoLaus Datacenter — Lausanne
- Department of Neurosurgery, Cantonal Hospital St. Gallen — Sankt Gallen
- Klinik Hirslanded — Zurich
- University College London — London
California
- University of California — San Francisco
Ohio
- University of Cincinnati College of Medicine — Cincinnati
Virginia
- University of Virginia — Virginia Beach
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20,000 participants |
| Start Date | 2015-06-01 |
| Est. Completion | 2040-03-01 |
Interested in This Trial?
Always speak with your doctor before enrolling in a clinical trial.
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05526352
The ClinicalTrials.gov registry entry for NCT05526352 describes a study currently listed as recruiting. It is categorized as an unspecified phase, which is the standard way researchers label where a study sits along the investigational pathway from early safety work through later efficacy and post-marketing evaluation. The registered enrollment target is 20,000 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University Hospital, Geneva, which has 3 total studies on file at ClinicalTrials.gov, and sponsors are the parties responsible for study design, oversight, and regulatory filings.
The record links to 1 condition, with Intracranial Aneurysm appearing as the primary indexed condition, and to 0 interventions. Interventions can include drugs, devices, procedures, behavioral programs, or observational arms, and each is tracked as a separate registry field so that downstream queries can filter accurately. When a trial lists multiple interventions, it usually reflects a multi-arm design or a comparison protocol rather than a single treatment being tested in isolation. The brief summary published in the registry is the clearest source of protocol intent and should be read before drawing conclusions from any sidebar tags.
Geographic footprint matters for practical reasons: NCT05526352 reports 20 study locations spanning 4 distinct geographic areas — top geographies include Other, California, Ohio. A larger site network tends to correlate with broader recruitment capacity, but it does not imply anything about study quality, and site-level enrollment status can diverge from the overall registry status shown above. Every data point on this page comes from the public ClinicalTrials.gov dataset and is reproduced here for reference only; it is not a medical recommendation, an endorsement of the sponsor, or an invitation to enroll. Verify current status, eligibility criteria, and contact details directly at ClinicalTrials.gov, and discuss any participation decision with your own healthcare provider.
Frequently Asked Questions
What is clinical trial NCT05526352 about?
NCT05526352 is a clinical study titled "@neurIST : Intregrated Biomedical Informatics for the Management of Cerebral Aneurysms". The primary aim of the SwissNeuroFoundation AneurysmDataBase Project is to implement information technology based tools to create and use a holistic reference database specific to intracranial aneurysms (IA). The SwissNeuroFoundation AneurysmDataBase are concerned with generating the data with whic...
What is the current status of trial NCT05526352?
This trial is currently recruiting. The enrollment target is 20,000 participants. The study started on 2015-06-01. Estimated completion is 2040-03-01.
What conditions does trial NCT05526352 study?
This clinical trial studies the following conditions: Intracranial Aneurysm. These conditions were identified from the trial registry and reflect the primary focus areas of the research.
Who is sponsoring clinical trial NCT05526352?
This trial is sponsored by University Hospital, Geneva, which has 3 total clinical trials registered on ClinicalTrials.gov. The sponsor is responsible for the study's design, funding, and regulatory compliance.
Where is trial NCT05526352 being conducted?
This trial has 20 study locations across California, Ohio, Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How Clinical Trials Work
Understand phases 1-4, trial design, randomization, and the informed consent process.
Patient Rights in Clinical Trials
Your rights as a participant: consent, withdrawal, privacy, and who to contact.
Finding the Right Clinical Trial
A practical guide to searching trials, understanding eligibility, and evaluating options.
All Guides
Browse our complete library of clinical trial educational resources.
Read our methodology — how this data is sourced, computed, and verified.